Discover OJJAARA (momelotinib), a treatment option for adults who have myelofibrosis (MF) with anemia. Learn about the study results for OJJAARA. See full Prescribing Info & Patient Info.

Access OJJAARA (momelotinib) to find info to questions about how to take OJJAARA and more. See full Prescribing Info and Patient Info.

Learn about OJJAARA (momelotinib). Ask your doctor if it's right for you. Visit OJJAARA website to learn more. See full Prescribing Info and Patient Info.

OJJAARA is a prescription medicine used to treat adults with certain types of myelofibrosis (MF) who have anemia. It is not known if OJJAARA is safe and effective in children. IMPORTANT SAFETY INFORMATION

Tell your healthcare provider right away if you have any signs of bleeding during treatment with OJJAARA, including: unusual bleeding; black or tarry stools; bruising; Liver problems. OJJAARA may cause new or worsening increased liver enzymes and bilirubin in your blood.

Learn about possible risks & side effects associated with OJJAARA. See full Prescribing Info and Patient Info. Access the website to learn more about study results for OJJAARA (momelotinib).

Discover OJJAARA (momelotinib) to access additional patient support and resources. See full Prescribing Info and Patient Info. Access the website to learn about OJJAARA (momelotinib).

OJJAARA is the first and only FDA-approved treatment specifically for adults with certain types of MF who have anemia. It is not known if OJJAARA is safe and effective in children.

View the study results for OJJAARA (momelotinib). Talk to your doctor to find out if OJJAARA could be right for you. See full Prescribing Info and Patient Info.

OJJAARA is a prescription medicine used to treat adults with certain types of myelofibrosis (MF) who have anemia. It is not known if OJJAARA is safe and effective in children.